More on FULC

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+77.4% Growth)
- Ratings (2.9 Score)

Upcoming Events

- Earnings (10/29/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Fulcrum Therapeutics Inc. (NQ:FULC)
Delayed: 3.65 -0.02 (0.54%)
Prev. Close $3.67  
Open$3.68 
52 Wk High$ 
52 Wk Low$ 
Day High$3.69 
Day Low$3.64 
P/E N/A  
EPS$ 
Volume1,385,330 

Friends, Peers and Foes (?): AGIO, ABVX, CRDO, HPE MCHP (more...)

Oct 8, 2026 05:10 PM Form S-4/A Fulcrum Therapeutics,
Aug 17, 2026 04:24 PM Form 425 Fulcrum Therapeutics, Filed by: Fulcrum Therapeutics, Inc.
Aug 17, 2026 08:33 AM Form 425 Fulcrum Therapeutics, Filed by: Fulcrum Therapeutics, Inc.
Aug 17, 2026 08:32 AM Form 425 Fulcrum Therapeutics, Filed by: Fulcrum Therapeutics, Inc.
Aug 17, 2026 08:30 AM Form 8-K Fulcrum Therapeutics, For: Aug 16
Aug 17, 2026 07:01 AM Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
Aug 17, 2026 07:00 AM Fulcrum Therapeutics and Slate Medicines Announce Merger Agreement to Advance Next-Generation Migraine Therapies
Aug 14, 2026 04:50 PM Form SCHEDULE 13G/A Fulcrum Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 14, 2026 04:47 PM Form SCHEDULE 13G Fulcrum Therapeutics, Filed by: Nantahala Capital Management, LLC
Aug 14, 2026 04:31 PM Form SCHEDULE 13G/A Fulcrum Therapeutics, Filed by: MONTANOVA CAPITAL, LLC
View All Articles

Entities mentioned with FULC

View All Entities